RegisterCANCOV Study: The Impact of COVID-19 on Lung Health
CANCOV Study: The Impact of COVID-19 on Lung Health
Webinar complete. Stay tuned for the live stream.
The Canadian COVID-19 Prospective Cohort Study (CANCOV) is a platform observational study that provides a comprehensive evaluation of early to 1-year outcomes in patients with COVID-19 and their family caregivers. Get early insights from this study on the impact of COVID-19 on lung health in this live webinar with Dr. Angela Cheung and Dr. Margaret Herridge.
Dr. Angela Cheung
Dr. Angela M. Cheung is a Professor of Medicine and the KY and Betty Ho Chair of Integrative Medicine at the University of Toronto. She is an Internal Medicine specialist and senior scientist at the University Health Network and holds a Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health. She obtained her MD from Johns Hopkins University and completed her training in General Internal Medicine at the University of Toronto and Beth Israel Deaconess Hospital in Boston, and her Ph.D. from Harvard University.
Dr. Margaret Herridge
Dr. Margaret S. Herridge is a Professor of Medicine, Critical Care and Pulmonary Medicine at the University Health Network; Senior Scientist in the Toronto General Research Institute; Director of Research for the Interdepartmental Division of Critical Care Medicine, University of Toronto. She obtained her MD from Queen’s University at Kingston, completed her clinical training in Respiratory and Critical Care Medicine at the University of Toronto and obtained her MPH at the Harvard School of Public Health.